Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
About this study
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
- Condition
- Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC)
- Tested
- SIRT
- Sponsor
- Sirtex Medical
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Study condition: Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC)
- Age 18 years or older
- Confirmed diagnosis of:
- Unresectable hepatocellular carcinoma (HCC) Or
- Unresectable liver metastases from colorectal cancer (mCRC) refractory to or intolerant to chemotherapy
- Identified as a candidate for SIR-Spheres treatment as deemed appropriate during the normal course of practice
- Planned to receive SIR-Spheres treatment to the liver for the first time
- Provision of signed patient informed consent
Exclusion 5
- Prior radiation treatment to the liver
- Caveat:
- Sequential selective internal radiation therapy (SIRT) treatment is allowed
- Patients participating in any interventional clinical trial with an investigational product, device, or procedure
- Need for surrogate consent. Patients who are not able to consent on behalf of themselves are not eligible.
Where
9 sites, 9 recruiting
Hôpital Beaujon
Clichy, Cedex, France
Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud
Pierre-Bénite, Rhône, France
Hopital Henri Mondor
Créteil, Paris, France
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Universitario Puerta de Hierro - Majadahonda
Majadahonda, Madrid, Spain
Hospital Clinico Universitario de Valencia
Valencia, Spain
and 3 more sites on ClinicalTrials.gov
Contact
-
Janet Bell
781-721-3840 jbell@sirtex.com
Potential match only. Final eligibility is determined by the study team.